Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis

Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis

Resource Type

CF Research News

Authors

Carsten Schwarz, Claudia Brandt, Volker Melicha, Christoph Runge, Eberhard Heuer, Hany Sahly, Martin Schebek, Holger Köster, Jean-Philippe Bouchara, Thomas Biedermann, Peter Meißner, Jörg Große-Onnebrink, Heino Skopnik, Dominik Hartl, Ludwig Sedlacek
Kathrin Tintelnot

References

J Cyst Fibros. 2018 Oct 5. pii: S1569-1993(18)30794-X. doi: 10.1016/j.jcf.2018.08.012

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Anti-fungal treatment [3]
Mycosis [4]
Pneumonia [5]

Date

Friday, October 5, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/combined-antifungal-therapy-superior-monotherapy-pulmonary

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-00126R2_FINAL_Schwarz_081118.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Combined%20antifungal%20therapy%20is%20superior%20to%20monotherapy%20in%20pulmonary%20scedosporiosis%20in%20cystic%20fibrosis [3] https://www.ecfs.eu/research-article-keywords/anti-fungal-treatment [4] https://www.ecfs.eu/research-article-keywords/mycosis [5] https://www.ecfs.eu/research-article-keywords/pneumonia [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines